Literature DB >> 10357206

Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cells.

O B Spiller1, C L Harris, B P Morgan.   

Abstract

The generation of antibodies is one of the first requirements in the characterisation of a newly cloned protein. However, this requires expression and purification of the protein in sufficient yield and purity for immunisation of animals and screening of fusion wells. Even with the development of highly efficient protocols based upon incorporation of specific peptide tags, this can be a tedious and time-consuming process. In an effort to improve the speed and efficiency of obtaining antibodies reactive with newly cloned proteins we have developed an approach based upon the expression of the protein at high level in cell lines originating from the species to be used for immunisation. To illustrate this approach we describe the generation of antibodies against two recently cloned proteins that are normally expressed at the membrane, the rat and mouse analogues of human decay accelerating factor (DAF; CD55). However, the strategy is applicable not only to membrane proteins but also to other proteins which can be expressed on the cell membrane by incorporating at the carboxy terminus the signal sequence for glycosyl phosphatidylinositol (GPI) anchor addition derived from DAF or another GPI-anchored protein. The strategy also permits rapid and efficient screening using flow cytometry on expressing cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357206     DOI: 10.1016/s0022-1759(99)00008-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  17 in total

1.  Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein.

Authors:  O Brad Spiller; Mairi Robinson; Elizabeth O'Donnell; Steven Milligan; B Paul Morgan; Andrew J Davison; David J Blackbourn
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies.

Authors:  F Lin; Y Fukuoka; A Spicer; R Ohta; N Okada; C L Harris; S N Emancipator; M E Medof
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

3.  Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity.

Authors:  T Miwa; X Sun; R Ohta; N Okada; C L Harris; B P Morgan; W C Song
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

4.  Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison.

Authors:  Claire L Harris; S Melanie Hanna; Masashi Mizuno; Dewi S Holt; Kevin J Marchbank; B Paul Morgan
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

5.  Augmenting DAF levels in vivo ameliorates experimental autoimmune encephalomyelitis.

Authors:  Qing Li; Danping Huang; Kristine Nacion; Hong Bu; Feng Lin
Journal:  Mol Immunol       Date:  2009-08-05       Impact factor: 4.407

6.  Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities.

Authors:  C L Harris; O B Spiller; B P Morgan
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

7.  Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis.

Authors:  Zhidan Tu; Qing Li; Hong-Shiue Chou; Ching-Chuang Hsieh; Howard Meyerson; Marion G Peters; Hong Bu; John J Fung; Shiguang Qian; Lina Lu; Feng Lin
Journal:  Immunobiology       Date:  2010-08-19       Impact factor: 3.144

8.  Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivo.

Authors:  C L Harris; A S Williams; S M Linton; B P Morgan
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

9.  Mouse CD4+ CD25+ T regulatory cells are protected from autologous complement mediated injury by Crry and CD59.

Authors:  Qing Li; Kristine Nacion; Hong Bu; Feng Lin
Journal:  Biochem Biophys Res Commun       Date:  2009-03-10       Impact factor: 3.575

10.  The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice.

Authors:  Ruth D Lewis; Christopher L Jackson; B Paul Morgan; Timothy R Hughes
Journal:  Mol Immunol       Date:  2009-12-02       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.